{
    "SPADE_UN_15315": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15315",
            "Peptide Name": "NK23a",
            "Source": "Synthetic",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "KISKKIMRTFLRRISKDILTGKK",
            "Sequence Length": 23,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:HeLa (Not active up to 100 µg/ml)",
            "Hemolytic Activity": "Human erythrocytes:<5% Hemolysis=100 µg/ml",
            "Cytotoxicity": "Not available",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C124H226N38O30S",
            "Mass": 2761.42,
            "PI": 11.76,
            "Net Charge": 8,
            "Hydrophobicity": -0.59,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Literature": [
                {
                    "Title": "Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens",
                    "Pubmed ID": "17389605",
                    "Reference": "J Biol Chem. 2007 May 18;282(20)14719-28.",
                    "Author": "Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17389605"
                },
                {
                    "Title": "Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol",
                    "Pubmed ID": "",
                    "Author": "Andra J, Goldmann T, Ernst CM, Peschel A, Gutsmann T"
                }
            ],
            "Frequent Amino Acids": "KIR",
            "Absent Amino Acids": "ACEHNOPQUVWY",
            "Basic Residues": 9,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 8,
            "Polar Residues": 13,
            "Positive Residues": 9,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_16182",
                    "Similarity": 1.0,
                    "Sequence": "KISKKIMRTFLRRILTGKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_16187",
                    "Similarity": 1.0,
                    "Sequence": "KISKKIMRTFLRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_16178",
                    "Similarity": 1.0,
                    "Sequence": "KKIMRTFLRRISKDILTGKK"
                }
            ]
        }
    }
}